E-LIB Suche - Ergebnisse für: Ke, E-E

1

PD-L1 expression guidance on sintilimab versus pembrolizuma..:

Maggie Liu, Si-Yang ; Huang, Jie ; Deng, Jia-Yi...
Science Bulletin. 69 (2024) 4 - p. 535-543 , 2024

Link: https://doi.org/10.1016/..

2

Genomic and immune characteristics of HER2‐mutated non‐smal..:

Tu, Hai‐Yan ; Yin, Kai ; Zhao, Xiaotian...
Molecular Oncology. 17 (2023) 8 - p. 1581-1594 , 2023

Link: https://doi.org/10.1002/..

3

Targeting Filamin A alleviates ovariectomy-induced bone los..:

Yang, Changsheng ; Yang, Panpan ; Liu, Peilin...
Cellular Signalling. 90 (2022) - p. 110191 , 2022

Link: https://doi.org/10.1016/..

4

Intratumoral genetic and immune microenvironmental heteroge..:

Zhang, Jia−Tao ; Dong, Song ; Ji, Li−Yan...
Thoracic Cancer. 13 (2022) 9 - p. 1333-1341 , 2022

Link: https://doi.org/10.1111/..

5

Genetic Profiling of Cell-Free DNA From Pleural Effusion in..:

Tu, Hai-Yan ; Li, Yang-Si ; Bai, Xiao-Yan...
Clinical Lung Cancer. 23 (2022) 2 - p. 135-142 , 2022

Link: https://doi.org/10.1016/..

6

A comprehensive review of uncommon EGFR mutations in patien..:

Tu, Hai-Yan ; Ke, E-E ; Yang, Jin-Ji...
Lung Cancer. 114 (2017) - p. 96-102 , 2017

Link: https://doi.org/10.1016/..

7

P3.02b-016 An Exploration Study of Mechanisms Underlying Pr..:

Ke, Ee ; Chen, Zhihong ; Su, Jian...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1195-S1196 , 2017

Link: https://doi.org/10.1016/..

8

P3.02b-095 Tracing Spatiotemporal T790M Heterogeneity in Pa..:

Zhang, Yi-Chen ; Pi, Can ; Ke, E-E...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1249 , 2017

Link: https://doi.org/10.1016/..

9

Distribution and prognosis of uncommon metastases from non-..:

Niu, Fei-Yu ; Zhou, Qing ; Yang, Jin-Ji...
BMC Cancer. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

10

The role of T790M mutation in EGFR-TKI re-challenge for pat..:

Zhang, Qiuyi ; Ke, Ee ; Niu, Feiyu...
Oncotarget. 8 (2016) 3 - p. 4994-5002 , 2016

Link: https://doi.org/10.18632..

11

Afatinib in the first-line treatment of epidermal-growth-fa..:

Ke, E-E ; Wu, Yi-Long
Therapeutic Advances in Respiratory Disease. 10 (2016) 3 - p. 256-264 , 2016

Link: https://doi.org/10.1177/..

12

EGFR as a Pharmacological Target in EGFR -Mutant Non-Small-..:

-->Ke, E-->-E ; Wu, Yi-Long
Trends in Pharmacological Sciences. 37 (2016) 11 - p. 887-903 , 2016

Link: https://doi.org/10.1016/..

13

Genomic and immune characteristics of HER2‐mutated non‐smal..:

Tu, Hai‐Yan ; Yin, Kai ; Zhao, Xiaotian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399722/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Intratumoral genetic and immune microenvironmental heteroge..:

Zhang, Jia−Tao ; Dong, Song ; Ji, Li−Yan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058296/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Afatinib in the first-line treatment of epidermal-growth-fa..:

Ke, E-E ; Wu, Yi-Long
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933608/. , 2016

Link: http://www.ncbi.nlm.nih...